Tinavi Medical Technologies Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Tinavi Medical Technologies Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.50 Million ≈ $3.59 Million USD) by net assets (CN¥1.29 Billion ≈ $189.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tinavi Medical Technologies Co Ltd (2013–2025)

Cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2025. This chart illustrates how Tinavi Medical Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688277 share price today for real-time trading data and today's change.

Tinavi Medical Technologies Co Ltd Cash Flow Conversion Ratio Explained

Tinavi Medical Technologies Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tinavi Medical Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their cash flow conversion efficiency. Also see Tinavi Medical Technologies Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Zoomlion Heavy Industry Science and Technology Co. Ltd
F:8CZ
0.019x
Under Armour Inc A
NYSE:UAA
0.194x
STEVANATO GROUP SPA O.N.
F:87N
0.021x
Weibo Corporation
F:2WBA
0.062x
eXp World Holdings Inc
NASDAQ:EXPI
0.123x
Neuberger Berman Next Generation Connectivity Fund Inc
NYSE:NBXG
N/A
Allied Machinery Co. Ltd.
SHG:605060
N/A
Harbin Electric
F:HP6H
0.036x

Annual Cash Flow Conversion Efficiency for Tinavi Medical Technologies Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2025. Review 688277 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.01 Billion
≈ $439.93 Million
CN¥-51.17 Million
≈ $-7.49 Million
-0.017x +77.92%
2024-12-31 CN¥1.28 Billion
≈ $187.32 Million
CN¥-98.65 Million
≈ $-14.44 Million
-0.077x +44.06%
2023-12-31 CN¥1.24 Billion
≈ $181.09 Million
CN¥-170.50 Million
≈ $-24.95 Million
-0.138x -75.95%
2022-12-31 CN¥1.12 Billion
≈ $163.54 Million
CN¥-87.51 Million
≈ $-12.80 Million
-0.078x -7.51%
2021-12-31 CN¥1.07 Billion
≈ $156.22 Million
CN¥-77.76 Million
≈ $-11.38 Million
-0.073x -29.85%
2020-12-31 CN¥1.03 Billion
≈ $150.22 Million
CN¥-57.58 Million
≈ $-8.43 Million
-0.056x -262.91%
2019-12-31 CN¥596.34 Million
≈ $87.26 Million
CN¥20.53 Million
≈ $3.00 Million
0.034x +46.76%
2018-12-31 CN¥560.61 Million
≈ $82.04 Million
CN¥13.15 Million
≈ $1.92 Million
0.023x -30.62%
2017-12-31 CN¥169.41 Million
≈ $24.79 Million
CN¥5.73 Million
≈ $838.18K
0.034x +114.13%
2016-12-31 CN¥136.62 Million
≈ $19.99 Million
CN¥-32.70 Million
≈ $-4.78 Million
-0.239x -216.74%
2015-12-31 CN¥203.98 Million
≈ $29.85 Million
CN¥41.82 Million
≈ $6.12 Million
0.205x +132.02%
2014-12-31 CN¥52.84 Million
≈ $7.73 Million
CN¥-33.84 Million
≈ $-4.95 Million
-0.640x -460.95%
2013-12-31 CN¥29.60 Million
≈ $4.33 Million
CN¥-3.38 Million
≈ $-494.53K
-0.114x --

About Tinavi Medical Technologies Co Ltd

SHG:688277 China Medical Instruments & Supplies
Market Cap
$1.05 Billion
CN¥7.19 Billion CNY
Market Cap Rank
#8423 Global
#1947 in China
Share Price
CN¥15.76
Change (1 day)
+4.79%
52-Week Range
CN¥13.68 - CN¥27.95
All Time High
CN¥141.60
About

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more